Fraud Scandal Costs GSK $3 Billion

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

July 3 (Bloomberg) -- GlaxoSmithKline Plc agreed to plead guilty and pay $3 billion to resolve criminal and civil allegations that it illegally promoted prescription drugs and failed to report safety data, the U.S. said. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change